Home › AstraZeneca in $560 m deal for respiratory firm
 

Keywords :   


AstraZeneca in $560 m deal for respiratory firm

2013-06-10 15:26:14| Biotech - Topix.net

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Tags: deal firm respiratory astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Tech giants dominate U.S. streaming platform market
08.11Warner Bros. Discovery adds 7.2 million DTC subscribers in 3Q 2024
08.11Polyurea-Based Lining is Key to GRE Pipeline Rehab Project in UAE
08.11Parents paying over the odds for baby milk, watchdog warns
08.11Sports fans driving global growth in streaming services
08.11TiVo OS footprint approaching one million activated Smart TVs
08.11The Entertainer axes new shops after Budget tax rise
08.11Hurricane Rafael Graphics
More »